Incyte to Report First Quarter Financial Results
11 April 2023 - 2:00PM
Business Wire
Incyte (Nasdaq:INCY) announced today that it has scheduled its
first quarter financial results conference call and webcast for
8:00 a.m. ET on Tuesday, May 2, 2023.
- The schedule for the press release and conference call/webcast
is as follows:
- Q1 2023 Press Release: May 2, 2023 at 7:00 a.m. ET
- Q1 2023 Conference Call: May 2, 2023 at 8:00 a.m. ET
- Domestic Dial-In Number: 877-407-3042
- International Dial-In Number: 201-389-0864
- Conference ID Number: 13737924
If you are unable to participate, a replay of the conference
call will be available for thirty days. The replay dial-in number
for the U.S. is 877-660-6853 and the dial-in number for
international callers is 201-612-7415. To access the replay
you will need the conference ID number 13737924.
The live webcast with slides can be accessed at
Investor.Incyte.com and will be available for replay for ninety
days.
About Incyte Incyte is a Wilmington, Delaware-based,
global biopharmaceutical company focused on finding solutions for
serious unmet medical needs through the discovery, development and
commercialization of proprietary therapeutics. For additional
information on Incyte, please visit Incyte.com and follow
@Incyte.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230411005060/en/
Media Catalina Loveman +1 302 498 6171
cloveman@incyte.com
Investors Christine Chiou +1 302 274 4773
cchiou@incyte.com
Incyte (NASDAQ:INCY)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Incyte (NASDAQ:INCY)
Historical Stock Chart
Von Apr 2023 bis Apr 2024